Allergan Aesthetics (AbbVie) CoolSculpting Elite
Cryolipolysis · Cryolipolysis
What it's actually cleared for: Cold-assisted lipolysis of abdomen, flanks, thighs, bra/back fat, banana roll, upper arms (BMI <=30) and submental area
Last verified: August 6, 2026 · How we verify
New: $150k–$250k with dual applicators|Used: $60k–$120k (legacy units $15k–$45k)market estimate, no email required
Bottom line
(Existing profile covers economics.) Buy the brand and the walk-in demand, not the margins — and model your cycle-card exposure honestly before signing.
Overview
Bottom line: buy the brand and the walk-in demand, not the margins. Model your cycle-card exposure honestly before signing and negotiate cycle bundles hard. If your market does not already know CoolSculpting by name, Emsculpt NEO or truSculpt iD money works harder. Alternatives: Emsculpt NEO, truSculpt iD, Cooltech Define (no US brand power, no cycle tax), EON. Prices are indicative 2026 US market ranges.
How it works
The science
Cryolipolysis: controlled cooling (around -11C at the cup) crystallizes lipids in fat cells, triggering apoptosis while sparing skin, nerves, and muscle, with dead adipocytes cleared over 1-3 months. Elite's dual applicators treat two areas simultaneously with redesigned C-shaped cups claiming better tissue contact and ~18% more cooling coverage than Legacy. ~20-25% fat-layer reduction per cycle in treated areas is the standard published expectation. Rare but real risk: paradoxical adipose hyperplasia (PAH) — treated fat grows instead of shrinking — which gained mainstream attention after high-profile cases; incidence estimates vary widely (roughly 1 in 2,000-4,000 cycles in published series). Every consult should disclose it.
Patented tech
Cryolipolysis itself originated from Harvard/Mass General research (Zeltiq's founding IP); Elite's C-shaped dual applicators and cup geometry are the current patent layer.
Origin
Zeltiq heritage manufacturing in Pleasanton, California under Allergan/AbbVie — verify current site.
FDA & regulatory status
What it's actually cleared for:
Cold-assisted lipolysis of abdomen, flanks, thighs, bra/back fat, banana roll, upper arms (BMI <=30) and submental area
510(k) numbers
K212707; K233732
Clearance notes
K212707 / K233732 lineage — cold-assisted lipolysis of the abdomen, flanks, thighs, bra/back fat, banana roll and upper arms (BMI ≤30) and submental area (BMI ≤46.2).
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Treatment economics
Consumers pay $600–$1,500 per cycle and typical plans run 4–8 cycles ($2,000–$4,500). But every cycle sends ~$330 back to Allergan — consumables were ~45–49% of Zeltiq revenue before the acquisition and cycle-card prices have roughly tripled since the late 2010s. A busy practice can owe Allergan $400k+/year. The brand still prints demand, but per-treatment margins are the thinnest of any major body device.
What practices charge
(Existing profile.) $600-1,500 per cycle, plans 4-8 cycles, $2,000-4,500 typical total.
Consumables & recurring cost
(Existing profile.) ~$330 per cycle card to Allergan plus gel/liner kits — consumables were ~45-49% of Zeltiq revenue pre-acquisition.
Consumables (summary)
~$330 per cycle card paid to Allergan plus gel/liner kit. Service negotiated; assume five figures annually.
Ideal for
Best-fit practice
Practices in markets where "CoolSculpting" is the search term — the brand still prints demand. Best inside the Allergan/Alle ecosystem cross-selling tox and filler patients. Patients: BMI <=30 (submental <=46.2), pinchable discrete fat pockets, needle- and surgery-averse.
Compliance
Medical director & delegation
Class II prescription device; medical director oversight with delegation to trained staff in most states — verify locally.
Contraindications & screening
Cryoglobulinemia, cold agglutinin disease, paroxysmal cold hemoglobinuria (absolute — cold-triggered blood disorders), pregnancy, hernias in the treatment area, impaired sensation; PAH risk disclosure belongs in every consent.
Ownership
Warranty & service
Negotiated with Allergan; assume five figures annually class-typical; cycle-card bundle negotiations matter more than the service line.
Resale & used market
Elite used at ~$60k-120k, Legacy far cheaper ($15k-45k); liquidity good but every buyer inherits the cycle-card economics, which caps what the hardware alone is worth.
Chains using this device
Ideal Image
Aesthetic chain · ~157 US locations · Chain treatment menu
Highbodenvy
Body contouring franchise · ~10 US locations · Company claims #1 US provider
HighSKINNEY Medspa
Medspa · 4 US locations · Treatment menu
MediumRed Mountain Weight Loss
Weight loss & aesthetics · 9 US locations · Service pages
MediumLaserAway
Aesthetic dermatology chain · ~200 US locations · Chain treatment menu
HighSchweiger Dermatology Group
Dermatology group · ~120 offices US locations · Practice service pages
MediumSkinSpirit
Medspa · 60 US locations · Chain treatment menu
MediumOrangeTwist
Medspa franchise · ~10 US locations · Chain treatment menu
Medium
Owner reviews
Write a reviewNo approved reviews yet. Be the first owner to publish one.
Alternatives
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first independent census of the US aesthetic device market — free.